Sign in
CompletedNo phase

Radiofrequency Applications and Alcoholic Neurolysis of Genicular Nerve for the Treatment of Knee Osteoarthritic Pain

Key facts

Who runs it
Tanta University
Where
Egypt1 site in 1 countryChoose a country to see its sites
Trial code
Status
Completed
People taking part
100 people enrolled
Started
25 Jul 2024
Ended
5 Jan 2025
Type of study
Interventional, 4 groups
Treatments tested
  • Radiofrequency
  • Alcohol 30%
  • Alcohol 50%
  • Alcohol 70%
Record updated
28 January 2025

Who can take part

Age
18 years and older
Sex
Women and men
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 12 criteriaShow less

Who can take part

  • Age > 18 years old
  • Both sexes
  • Patients with knee osteoarthritis
  • Previous conservative treatments longer than 3 months
  • visual analog scale (VAS)≥ 4
  • Radiological osteoarthritis grades 3 and 4 according to the Kellgren-Lawrence grading system (0 = none, 1 = doubtful, 2 = minimal, 3 = moderate, and 4 = severe)

Who cannot take part

  • Anticoagulant therapy
  • Injection with steroids or hyaluronic acids during the previous 3 months
  • History of knee surgery
  • Serious neurologic or psychiatric disorders
  • Patient refusal
  • Radiculopathy

This trial has no sites in United States.

It has sites in one country. Choose a country to see its sites.

About the trial

What the trial wants to find out

This study aims to investigate the efficacy of radiofrequency ablation and alcoholic neurolysis of genicular nerve on alleviating pain and improving the function of advanced knee osteoarthritis patients.

The 4 groups in the trial

  • Radiofrequency groupTreatment being tested

    Patients will receive radiofrequency.

    Treatment: Radiofrequency

  • 30% alcohol groupTreatment being tested

    Patients will receive ultrasound-guided injection of each of the three genicular nerves with 0.5-0.75 ml of a solution containing 30% alcohol in 0.25% bupivacaine.

    Treatment: Alcohol 30%

  • 50% alcohol groupTreatment being tested

    Patients will receive ultrasound-guided injection of each of the three genicular nerves with 0.5-0.75 ml of a solution containing 50% alcohol in 0.25% bupivacaine.

    Treatment: Alcohol 50%

  • 70% alcohol groupTreatment being tested

    Patients will receive ultrasound-guided injection of each of the three genicular nerves with 0.5-0.75 ml of a solution containing 70% alcohol in 0.25% bupivacaine.

    Treatment: Alcohol 70%

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Comparison of Radiofrequency Applications and Alcoholic Neurolysis of Genicular Nerve for the Treatment of Knee Osteoarthritic Pain: A Randomized Trial
Record updated
28 January 2025